<DOC>
	<DOCNO>NCT00725140</DOCNO>
	<brief_summary>This observational , open , prospective , single arm cohort study within authorized SPC condition describe effectiveness Almotriptan treat acute migraine attack pain mild first hour pain everyday primary care clinical practice .</brief_summary>
	<brief_title>Standardized sTudy With Almotriptan eaRly Treatment Migraine</brief_title>
	<detailed_description>Primary Objective : To describe effectiveness Almotriptan treat acute migraine attack pain mild first hour pain everyday primary care clinical practice . Secondary Objectives : 1 . Influence educational intervention early intake treatment 2 . Influence medication history concomitant medication treatment result 3 . Influence migraine trigger treatment result 4 . Influence stress treatment result 5 . Tolerability profile validation 6 . Patients ' satisfaction 7 . Reasons delay migraine treatment intake</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Almotriptan</mesh_term>
	<criteria>1 . History confirm diagnosis migraine meet IHS diagnosis criterion migraine without aura least one year . 2 . Patients history migraine headache progress mild least moderate pain intensity untreated scale pain ( 0 ) , mild ( 1 ) , moderate ( 2 ) , severe ( 3 ) within past year . 3 . Migraine headache frequency 2 6 per month past 3 month . 4 . Male female age 18 65 year . 5 . Able differentiate migraine headache interval ( e.g. , tensiontype ) headache . 8.Female patient childbearing potential must suspect pregnant effective method birth control least 30 day prior study entry throughout study . 11.After full explanation , patient must sign informed consent document indicate understand purpose procedure require study willing participate study . 12.Patients must either use Almotriptan migraine acute attack treatment prove ANAES scale basal visit change treatment approach require . 1 . Patients , opinion investigator , enrol study precaution , warning contraindication section Almotriptan Summary Product Characteristics . 2 . Patients 15 headache day per month previous 6 month ( chronic daily headache ) , patient migraine headache frequency 6 per month past 3 month . 3 . Patients onset migraine age 50 . 4 . Patients routinely experience type headache would confound discrimination migraine . 5 . Patients exclusively migraine aura without headache . 6 . Patients typically experience vomit headache . 7 . Patients hemiplegic basilar type migraine . 8 . Patients typically headaches occur predominantly upon awaken morning . 9 . Patients previously discontinue Almotriptan therapy due adverse event lack efficacy . 11.Patients take prohibit concomitant medication list Section 10.3.1 protocol . 12.Patients use follow medication within 7 day study entry trial : sustained release opioids and/or semisynthetic long act opioids . 16.Women pregnant lactating . 18.Patients receive investigational drug use investigational device within 30 day study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Early intervention</keyword>
	<keyword>Primary Care</keyword>
	<keyword>Almotriptan</keyword>
</DOC>